Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Icu Medical (ICUI) EBIAT (2016 - 2025)

Icu Medical's EBIAT history spans 17 years, with the latest figure at -$15.7 million for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT rose 33.97% year-over-year to -$15.7 million, compared with a TTM value of $732000.0 through Dec 2025, up 100.62%, and an annual FY2025 reading of $732000.0, up 100.62% over the prior year.
  • EBIAT for Q4 2025 was -$15.7 million at Icu Medical, down from -$3.4 million in the prior quarter.
  • The five-year high for EBIAT was $35.3 million in Q2 2025, with the low at -$39.5 million in Q1 2024.
  • Average EBIAT over 5 years is -$5.9 million, with a median of -$11.6 million recorded in 2022.
  • Year-over-year, EBIAT crashed 555.69% in 2024 and then skyrocketed 265.08% in 2025.
  • Tracing ICUI's EBIAT over 5 years: stood at $19.9 million in 2021, then crashed by 177.97% to -$15.5 million in 2022, then fell by 10.37% to -$17.1 million in 2023, then crashed by 38.96% to -$23.8 million in 2024, then surged by 33.97% to -$15.7 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's EBIAT are -$15.7 million (Q4 2025), -$3.4 million (Q3 2025), and $35.3 million (Q2 2025).